Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

Apr 29 • 04:00PM ET

71.89

+3.26 4.75 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AMGN GILD REGN VRTX BIIB MRNA BMY PFE LLY NVS

| Held by: IWM VTI XBI VXF IBB IWO SCHA VTWO IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.08	Insider Own	17.79%	Shs Outstand	78.19M	Perf Week	-1.52%
Market Cap	6.18B	Forward P/E	-	EPS next Y	-3.09	Insider Trans	-0.89%	Shs Float	70.71M	Perf Month	58.28%
Enterprise Value	5.58B	PEG	-	EPS next Q	-0.67	Inst Own	85.35%	Short Float	16.51%	Perf Quarter	116.93%
Income	-135.82M	P/S	-	EPS this Y	-44.70%	Inst Trans	22.23%	Short Ratio	11.62	Perf Half Y	192.59%
Sales	0.00M	P/B	10.05	EPS next Y	-7.79%	ROA	-19.59%	Short Interest	11.67M	Perf YTD	119.44%
Book/sh	7.15	P/C	8.17	EPS next 5Y	-18.86%	ROE	-22.03%	52W High	75.00 -4.15%	Perf Year	378.63%
Cash/sh	8.80	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-18.99%	52W Low	12.28 485.19%	Perf 3Y	1604.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.94% 7.28%	Perf 5Y	-64.97%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	34.23%	Oper. Margin	-	ATR (14)	4.40	Perf 10Y	-67.17%
Dividend Ex-Date	-	Quick Ratio	13.25	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	69.07	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	13.25	EPS Q/Q	12.65%	SMA20	14.14%	Beta	3.11	Target Price	90.53
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	41.53%	Rel Volume	1.79	Prev Close	68.63
Employees	102	LT Debt/Eq	0.00	Earnings	Feb 19 AMC	SMA200	134.44%	Avg Volume	1.00M	Price	71.89
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.30% -	Trades		Volume	1,808,270	Change	4.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)